21
Philosophy, Religion & Society / Re: Died Suddenly
« Last post by stack on February 05, 2023, 09:25:48 AM »Ah...the good old, "according to [unnamed sources], who told us such and such," trick.What changes did they make to the data to change the numbers after the criticism of this?
« Reply #154 on: February 03, 2023, 12:19:17 AM »It is pretty clear that health authorities are not being entirely honest with us:
https://gellerreport.com/2021/09/shocking-fraud-cdc-now-lists-vaccinated-deaths-as-unvaccinated.html/?utm_source=dlvr.it&utm_medium=twitter
The Most Influential Spreader of Coronavirus Misinformation Online
Researchers and regulators say Joseph Mercola, an osteopathic physician, creates and profits from misleading claims about Covid-19 vaccines.
Dr. Mercola, 67, an osteopathic physician in Cape Coral, Fla., has long been a subject of criticism and government regulatory actions for his promotion of unproven or unapproved treatments. But most recently, he has become the chief spreader of coronavirus misinformation online, according to researchers.
From the get-go, the entirety of official government reports, especially the "death by," numbers issued by the GOVERNMENTS across the world, has been nothing but lies.
Your willingness to not just DRINK but SELL their Kool-Aid is quite telling.
Interesting how you consider the FDA, who took "government regulatory actions" against Mercola, an "unnamed source". That's a new one.
The FDA has observed that your website offers “Liposomal Vitamin C,” “Liposomal Vitamin D3,” and “Quercetin and Pterostilbene Advanced” products for sale in the United States and that these products are intended to mitigate, prevent, treat, diagnose, or cure COVID-191 in people. Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 2pt1 U.S.C. § 355(a). Furthermore, these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352. The introduction or delivery for introduction of these products into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d).
You should take immediate action to address the violations cited in this letter. This letter is not meant to be an all-inclusive list of violations that exist in connection with your products or operations. It is your responsibility to ensure that the products you sell are in compliance with the FD&C Act and FDA's implementing regulations. We advise you to review your websites, product labels, and other labeling and promotional materials to ensure that you are not misleadingly representing your products as safe and effective for a COVID-19-related use for which they have not been approved by FDA and that you do not make claims that misbrand the products in violation of the FD&C Act.